Alnylam Pharmaceuticals Inc ALNY Phase 2 Diabetes Drug Progress and SP 500 Contender Status Lift Bullish Outlook GGRP The reports wider than expected Q1 2026 per share loss stock dips modestly post earnings NVT nVent delivers narrow Q4 2025 EPS miss sending share price down 067 percent in todays trading MNSBP MainStreet posts 242 percent Q1 2026 EPS beat shares remain flat in trading today Chegg CHGG Stock PricetoValue Assessment Q4 2025 Better Than Expected MBIA MBI Stock Investment Risk vs Reward MBIA posts 106 EPS miss wider than expected loss ALBT Avalon Globo climbs 336 percent following the release of its Q3 2023 earnings results The TJX Companies Inc TJX Is the OffPrice Retail Leader Still a Compelling Buy Amid Historic Outperformance